Clinical TrialsSearch results
Number of results: 293
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery
- tachyarrhythmia
- JL-Knight Study Group
- 2007-12-27
Other
- Clinical study on the efficacy of flutamide for androgen dependent dilated cardiomyopathy
- Dilated cardiomyopathy
- Onoue Kenji
- 2019-03-13
Other
- Clinical trial of ghrelin administration in patients with chronic obstructive pulmonary disease
- Chronic obstructive pulmonary disease
- National Cardiovascular Center Research Institute
- 2005-08-15
Other
- Clinical trial with ghrelin for patients with chronic respiratory failure
- chronic respiratory failure
- University of Miyazaki
- 2008-12-01
Other
- Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Recruiting
- COLE Study
- Oral lichen planus
- Yagyuu Takahiro
- 2022-12-09
Recruiting
- COmbination Strategy on renal function of the benidipine or diuretics treatMent with RAS inhibitOrs in CKD hypertensive population
- Hypertensive patients with albuminuria under the treatment of the inhibitor of the renin-angiotension system (RAS)
- COSMO-CKD Study Group
- 2009-07-01
Other
- Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial
- Outpatients who are required a combination therapy with sitting systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg
- COPE Trial Group
- 2008-05-12
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30